| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bb84901d8a367f534d9a9f394f62eb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_259697bb7506be6263dc8926165c2806 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-39 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_630d215a27aa9045a5e28b95e6a98b81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8c1f62bd56a31a7c4c5796a7d61f8e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0a1b0cd99b1dd4532a31d2272915222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a371e2bc86e87f2bb54b831f8a25788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a52a49ad454529593ca63320de92f305
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_544908f8340fb3370eb5343f2988fa75 |
| publicationDate |
2014-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20140142580-A |
| titleOfInvention |
Composition for prevention and treatment of inflammatory diseases comprising N-trans-ρ-caffeoyl tyramine compound isolated from Tribulus terrestris |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating an inflammatory disease comprising a compound having an excellent therapeutic effect for inflammatory diseases isolated from a bovine or a pharmaceutically acceptable salt thereof and a pharmaceutical composition for preventing or ameliorating inflammation comprising the compound A health functional food composition, and a method for treating an inflammatory disease in an animal other than a human, comprising administering the pharmaceutical composition to a suspect individual with an inflammatory disease. The composition according to the present invention can be effectively used for the prevention, treatment or improvement of an inflammatory disease, and the active ingredient of the present invention, N-trans-ρ-caffeoyl tyramine, As a result, it is possible to provide a safe therapeutic agent which is free from any adverse effects as compared with synthetic drugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4003060-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11642323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11647776-B2 |
| priorityDate |
2013-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |